Adam Urato: Understanding SSRI Impacts on Maternal and Fetal Serotonin Levels
Adam Urato, Maternal-Fetal Medicine Physician at MetroWest Medical Center, shared a post on X about a recent article by Amy L. Salisbury et al., published in Neuropsychopharmacology, adding:
“Remember, SSRIs have a profound chemical impact on a pregnant mom and her baby.
Platelet serotonin levels are dramatically lower for both and it’s likely there are similar effects in the brain, since SSRIs block the serotonin transporter (present in the brain and platelets).”
Title: Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect
Authors: Amy L. Salisbury, George M. Anderson, Amy Yang, Catherine S. Stika, Laura J. Rasmussen-Torvik, Jacqueline K. Gollan, Katherine L. Wisner
Stay updated with Hemostasis Today.
-
Oct 3, 2026, 17:26Karel Kostev։ When First Anticoagulant Prescriptions Are Not Dispensed
-
Oct 3, 2026, 17:11Nabila Hasan: Thalassemia Awareness And Prevention
-
Oct 3, 2026, 17:03Pasinee Sangsiwarit: Neutrophil Dysfunction In β-Thalassemia
-
Oct 3, 2026, 16:18Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH
-
Oct 3, 2026, 14:41How Much Do We Really Know About The Global Burden Of Venous Thromboembolism? – World Thrombosis Day